Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Tony Daltorio

1 Huge New Reason This Diet Drug Stock is a Must-Own

The popularity of Novo Nordisk’s (NVO) weight-loss drug, Wegovy, has already catapulted its stock to become Europe’s most valuable company, as measured by market capitalization.

Wegovy is a GLP-1 drug. Glucagon-like peptide-1 (GLP-1) agonists are a class of drugs used to treat type 2 diabetes and obesity. They mimic the action of GLP-1, a hormone released by the stomach after eating that signals the pancreas to produce more insulin and keep blood sugar levels normal.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.